Literature DB >> 30707035

Camouflaging Nanoparticles for Ratiometric Delivery of Therapeutic Combinations.

Fanfei Meng1,2, Jianping Wang1,2, Qineng Ping2, Yoon Yeo1,3.   

Abstract

Combination therapy is a common clinical practice in the management of malignancies. Synergistic therapeutic outcomes are achieved only when tumor cells are exposed to drugs in an optimal ratio and sequence; therefore, carriers coencapsulating multiple drugs are widely pursued for their coordinated delivery. However, it is challenging to coload drugs with different physicochemical properties in a single carrier with specific ratios. It is not even beneficial to load them in one carrier if they need to be released at different times. We propose to load drugs into chemically compatible carriers separately, equalize different carriers by a simple, rapid, and versatile camouflage technique based on natural polyphenol tannic acid (TA), and administer them in desirable ratios and sequences. To demonstrate this potential, different nanoparticles (NPs) with different charges and material basis, such as polymeric (carboxyl-terminated or amine-terminated cationic polystyrene NPs or poly(lactic- co-glycolic acid (PLGA) NPs), inorganic (mesoporous silica NPs (MSNs)), and liposomal NPs, are camouflaged with TA layers and further modified with folate-conjugated polyethylene glycol to aid in the delivery to tumors. The camouflaged NPs show similar physicochemical properties and interactions with KB cells despite the difference in core platforms, and their mixtures interact with common cell targets in a ratiometric manner. In KB-tumor-bearing mice, the camouflaged PLGA NPs and MSNs show near-perfect colocalization in tumors. These results support that TA helps equalize different NPs with high versatility and enables their ratiometric delivery to common targets. This approach can relieve technical challenges in ratiometric codelivery or sequential delivery of therapeutic agents with distinct physicochemical properties.

Entities:  

Keywords:  Combination therapy; coordinated delivery; nanoparticles; surface camouflage; tannic acid assembly

Mesh:

Substances:

Year:  2019        PMID: 30707035      PMCID: PMC6417971          DOI: 10.1021/acs.nanolett.8b04017

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  39 in total

1.  Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy.

Authors:  Nagesh Kolishetti; Shanta Dhar; Pedro M Valencia; Lucy Q Lin; Rohit Karnik; Stephen J Lippard; Robert Langer; Omid C Farokhzad
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  Theoretical analysis of antibody targeting of tumor spheroids: importance of dosage for penetration, and affinity for retention.

Authors:  Christilyn P Graff; K Dane Wittrup
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

Review 3.  Disorders of iron metabolism. Part II: iron deficiency and iron overload.

Authors:  Manuel Muñoz; José Antonio García-Erce; Ángel Francisco Remacha
Journal:  J Clin Pathol       Date:  2010-12-20       Impact factor: 3.411

4.  Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles.

Authors:  Z Panagi; A Beletsi; G Evangelatos; E Livaniou; D S Ithakissios; K Avgoustakis
Journal:  Int J Pharm       Date:  2001-06-19       Impact factor: 5.875

5.  Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention.

Authors:  Sanjeeb K Sahoo; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2005 Sep-Oct       Impact factor: 4.939

6.  TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs.

Authors:  Kavitha S Rao; Maram K Reddy; Jayme L Horning; Vinod Labhasetwar
Journal:  Biomaterials       Date:  2008-08-28       Impact factor: 12.479

7.  Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation.

Authors:  Matti M van Schooneveld; Esad Vucic; Rolf Koole; Yu Zhou; Joanne Stocks; David P Cormode; Cheuk Y Tang; Ronald E Gordon; Klaas Nicolay; Andries Meijerink; Zahi A Fayad; Willem J M Mulder
Journal:  Nano Lett       Date:  2008-07-12       Impact factor: 11.189

Review 8.  Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.

Authors:  Katherine A Lyseng-Williamson; Gillian M Keating
Journal:  Drugs       Date:  2009       Impact factor: 9.546

9.  In vitro and in vivo characterization of doxorubicin and vincristine coencapsulated within liposomes through use of transition metal ion complexation and pH gradient loading.

Authors:  Sheela A Abraham; Cheryl McKenzie; Dana Masin; Rebecca Ng; Troy O Harasym; Lawrence D Mayer; Marcel B Bally
Journal:  Clin Cancer Res       Date:  2004-01-15       Impact factor: 12.531

10.  Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier.

Authors:  M Juweid; R Neumann; C Paik; M J Perez-Bacete; J Sato; W van Osdol; J N Weinstein
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

View more
  5 in total

1.  Ratiometric Delivery of Mitoxantrone and Berberine Co-encapsulated Liposomes to Improve Antitumor Efficiency and Decrease Cardiac Toxicity.

Authors:  Zimeng Yang; Liwen Zhao; Xue Wang; Zhonggui He; Yongjun Wang
Journal:  AAPS PharmSciTech       Date:  2021-01-13       Impact factor: 3.246

Review 2.  Co-delivery systems: hope for clinical application?

Authors:  Sepideh Nezhadi; Farid Abedin Dorkoosh
Journal:  Drug Deliv Transl Res       Date:  2021-08-16       Impact factor: 4.617

3.  Enhanced Anti-Brain Metastasis from Non-Small Cell Lung Cancer of Osimertinib and Doxorubicin Co-Delivery Targeted Nanocarrier.

Authors:  Xiaoqi Wang; Wenxing Mao; Zhi Wang; Xinrui Li; Yaokun Xiong; Hongjin Lu; Xiuzhen Wang; Haoyuan Yin; Xiang Cao; Hongliang Xin
Journal:  Int J Nanomedicine       Date:  2020-08-03

4.  Calixarene-modified albumin for stoichiometric delivery of multiple drugs in combination-chemotherapy.

Authors:  Ying Wang; Zhanzhan Zhang; Xinzhi Zhao; Lina Xu; Yadan Zheng; Hua-Bin Li; Dong-Sheng Guo; Linqi Shi; Yang Liu
Journal:  Theranostics       Date:  2022-05-01       Impact factor: 11.600

Review 5.  Recent strategies for nano-based PTT combined with immunotherapy: from a biomaterial point of view.

Authors:  Xingyue Huang; Yang Lu; Mingxue Guo; Shouying Du; Ning Han
Journal:  Theranostics       Date:  2021-06-04       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.